| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.2B | — | — | — | — |
| Op. Income | $400M | — | — | — | — |
| Gross Margin | 45.7% | — | — | — | — |
| Net Margin | 24.3% | — | — | — | — |
| EPS (Diluted) | $4.05 | — | — | — | — |
| Free Cash Flow | $420M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $650M |
| GROSS PROFIT | $547M |
| R&D Expenses | $0 |
| Selling & Marketing | $35M |
| General & Administrative | $112M |
| SG&A Expenses | $147M |
| Other Expenses | $0 |
| Operating Expenses | $147M |
| Cost & Expenses | $797M |
| OPERATING INCOME | $400M |
| Interest Income | $12M |
| Interest Expense | $9M |
| Other Income/Expenses | $90M |
| INCOME BEFORE TAX | $489M |
| Income Tax Expense | $111M |
| Net Income from Continuing Ops | $378M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $290M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $266M |
| D&A | $9M |
| EBIT | $480M |
| EBITDA | $489M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $650M |
| GROSS PROFIT | $547M |
| R&D Expenses | $0 |
| Selling & Marketing | $35M |
| General & Administrative | $112M |
| SG&A Expenses | $147M |
| Other Expenses | $0 |
| Operating Expenses | $147M |
| Cost & Expenses | $797M |
| OPERATING INCOME | $400M |
| Interest Income | $12M |
| Interest Expense | $9M |
| Other Income/Expenses | $90M |
| INCOME BEFORE TAX | $489M |
| Income Tax Expense | $111M |
| Net Income from Continuing Ops | $378M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $290M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $266M |
| D&A | $9M |
| EBIT | $480M |
| EBITDA | $489M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $290M |
| Depreciation & Amortization | $9M |
| Stock-Based Compensation | $23M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $59M |
| Change in Working Capital | $38M |
| OPERATING CASH FLOW | $421M |
| Capital Expenditure | -$677.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$515M |
| Sales/Maturities of Investments | $302M |
| Other Investing Activities | $188M |
| NET CASH FROM INVESTING | -$25M |
| Net Debt Issuance | -$10M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$361M |
| NET CASH FROM FINANCING | -$371M |
| FREE CASH FLOW | $420M |
| Net Change in Cash | -$13M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $256M |
| Short-Term Investments | $0 |
| Net Receivables | $165M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $421M |
| PP&E (Net) | $138M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $638M |
| Tax Assets | $355M |
| Other Non-Current Assets | $25M |
| TOTAL NON-CURRENT ASSETS | $1.2B |
| TOTAL ASSETS | $1.6B |
| Account Payables | $0 |
| Short-Term Debt | $21M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $21M |
| Long-Term Debt | $289M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $300.0K |
| Other Non-Current Liabilities | $384M |
| TOTAL NON-CURRENT LIABILITIES | $774M |
| TOTAL LIABILITIES | $795M |
| Common Stock | $807.0K |
| Additional Paid-In Capital | $236M |
| Retained Earnings | $203M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $439M |
| Minority Interest | $344M |
| TOTAL EQUITY | $782M |
| TOTAL LIABILITIES & EQUITY | $1.6B |
| Total Debt | $410M |
| Net Debt | $155M |